TrialBMC gastroenterology2023

Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial.

Xiao-Dong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.